Drug Trial Radar · NCT07128628
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
Last checked: Nov 20, 2026Latest source record: Jul 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
443
Actual
Start
Oct 24, 2025
Primary completion
May 28, 2026
Study completion May 28, 2026
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Aug 19, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease
Conditions
- Dry Eye Disease
Interventions
Lifitegrast/Perfluorohexyloctane Fixed Dose CombinationDrug
Topical ocular drop of lifitegrast and perfluorohexyloctane administered for 4 weeks
LifitegrastDrug
Topical ocular drop of lifitegrast administered for 4 weeks
PerfluorohexyloctaneDrug
Topical ocular drop of perfluorohexyloctane administered for 4 weeks
VehicleDrug
Topical ocular drop with no active ingredients administered for 4 weeks
VehicleDrug
Topical ocular drop with no active ingredients administered for 4 weeks
VehicleDrug
Topical ocular drop with no active ingredients administered for 4 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total corneal fluorescein staining change from baselineTime frame: Baseline, day 29
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
Eye Doctors of Arizona, PLLC
Phoenix, Arizona
Global Research Management, Inc.
Glendale, California
SoCal Eye - Lakewood Clinic
Long Beach, California
LoBue Laser and Eye Medical Center
Murrieta, California
Eye Research Foundation, Inc.
Newport Beach, California
Wolstan and Goldberg Eye Associates
Torrance, California
Segal Drug Trials/Office of Bruce A Segal, MD
Delray Beach, Florida
Bowden Eye and Associates
Jacksonville, Florida
Shettle Eye Research, Inc
Largo, Florida
Clayton Eye Clinical Research, LLC
Morrow, Georgia
Midwest Cornea Associates LLC
Carmel, Indiana
Kannarr Eye Care, LLC
Pittsburg, Kansas
Vance Thompson Vision - Alexandria
Alexandria, Minnesota
Complete Eye Care of Medina
Medina, Minnesota
Insight Eyecare Specialties, Inc.
Kansas City, Missouri
Moyes Eye Center, P.C.
Kansas City, Missouri
Ophthalmology Consultants, Ltd.
St Louis, Missouri
Comprehensive Eye Care Ltd.
Washington, Missouri
Opthalmic consultants of Long Island
Garden City, New York
Rochester Ophthalmological Group,PC
Rochester, New York
Asheville Eye Associates
Asheville, North Carolina
Oculus Research
Garner, North Carolina
CORE Inc.
Shelby, North Carolina
Vance Thompson Vision - Fargo, ND
West Fargo, North Dakota
Insight Research Clinic LLC.
Powell, Ohio
Scott & Christie Eyecare Associates - The Surgery Center at Cranberry
Cranberry Township, Pennsylvania
West Bay Eye Associates
Warwick, Rhode Island
Southern College of Optometry
Memphis, Tennessee
Total Eye Care PA
Memphis, Tennessee
Advancing Vision Research, LLC
Smyrna, Tennessee
Intouch Clinical Research Center
Houston, Texas
Lake Travis Eye and Laser Center
Lakeway, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.